A Phase II, Randomized, Two Stage, Double-Blind, Placebo-Controlled Two-Dose, Safety and Immunogenicity Study of an Intramuscular Influenza Vaccine (Multimeric-001) Injected to Healthy Volunteers.

Trial Profile

A Phase II, Randomized, Two Stage, Double-Blind, Placebo-Controlled Two-Dose, Safety and Immunogenicity Study of an Intramuscular Influenza Vaccine (Multimeric-001) Injected to Healthy Volunteers.

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Jul 2012

At a glance

  • Drugs Influenza virus vaccine (Primary)
  • Indications Influenza virus infections
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 30 Jul 2012 Actual initiation date (July 2010) added as reported by ClinicalTrials.gov.
    • 16 Jun 2011 Status changed from recruiting to completed as reported in a BiondVax media release.
    • 16 Jun 2011 Results will be presented at the BIO International Convention.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top